Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area
ChemDiv a leading player in the field of drug discovery solutions worldwide has recently announced a strategic collaboration with the University of Texas Medical Branch
HU Group Holdings Inc and its whollyowned subsidiary Fujirebio have introduced the latest addition to their product linethe fully automated LUMIPULSE G immunoassay system Lumipulse G pTau plasma assay
ImmunoScape a biotechnology firm focusing on nextgeneration T Cell receptor based immunotherapies has recently announced a collaboration with the Experimental Drug Development Centre
Meilleur Technologies Inc has announced a new agreement with PharmaLogic Holdings Corporation The agreement grants PharmaLogic exclusive rights to manufacture fluorine
Theragent Inc a prominent Contract Development and Manufacturing Organization CDMO specializing in advancing cuttingedge cellbased therapies recently announced that CellVax Therapeutics Inc
MBrace Therapeutics Inc a clinicalstage biopharmaceutical company focused on enhancing the lives of cancer patients through the development of innovative antibodydrug conjugates
Biocytogen Pharmaceuticals Beijing Co Ltdrecently announced an agreement with Neurocrine Biosciences Inc involving the assessment of fully human antibodies against specified targets
Fluent BioSciences and Element Biosciences are pleased to announce their collaboration to enhance the accessibility and scalability of singlecell RNA sequencing Singlecell RNA sequencing is a vital tool for unraveling cellular and molecular diversity...
Anagenex and Nimbus Therapeutics have recently initiated a collaborative research venture focused on the discovery of small molecule drugs targeting challenging entities Anagenex a forwardthinking drug discovery
Telix Pharmaceuticals Limited has officially submitted its Biologics License Application to the United States Food and Drug Administration for TLXCDx an investigational positron emission tomography
